Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125034483 | 12503448 | 3 | F | 2016 | 20160719 | 20160628 | 20160721 | EXP | US-PFIZER INC-2016043191 | PFIZER | 53.00 | YR | F | Y | 74.39000 | KG | 20160721 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125034483 | 12503448 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | UNK | 20699 | PROLONGED-RELEASE CAPSULE | |||||||||
125034483 | 12503448 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 300 MG, 1X/DAY (2 ^TABLETS^, AT NIGHT) | 20699 | 300 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
125034483 | 12503448 | 3 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.5 MG, UNK | 0 | .5 | MG | TABLET | |||||||
125034483 | 12503448 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | TABLET | |||||||||||
125034483 | 12503448 | 5 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | TABLET | |||||||||||
125034483 | 12503448 | 6 | C | PREDNISONE. | PREDNISONE | 1 | 10 MG, UNK | 0 | 10 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125034483 | 12503448 | 1 | Depression |
125034483 | 12503448 | 3 | Depression |
125034483 | 12503448 | 4 | Nervousness |
125034483 | 12503448 | 5 | Anxiety |
125034483 | 12503448 | 6 | Systemic lupus erythematosus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125034483 | 12503448 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125034483 | 12503448 | Abdominal discomfort | |
125034483 | 12503448 | Abdominal pain upper | |
125034483 | 12503448 | Disease recurrence | |
125034483 | 12503448 | Dizziness | |
125034483 | 12503448 | Drug ineffective | |
125034483 | 12503448 | Middle insomnia | |
125034483 | 12503448 | Nasopharyngitis | |
125034483 | 12503448 | Prescribed overdose | |
125034483 | 12503448 | Product quality issue | |
125034483 | 12503448 | Systemic lupus erythematosus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |